Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis.

Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA.

J Neurosci. 2014 Apr 23;34(17):5765-75. doi: 10.1523/JNEUROSCI.5307-13.2014.

2.
3.

Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.

Srivastava AK, White HS.

Epilepsy Res. 2013 Mar;104(1-2):26-34. doi: 10.1016/j.eplepsyres.2012.10.003. Epub 2012 Nov 14.

4.

GluA2 AMPA glutamate receptor subunit exhibits codon 607 Q/R RNA editing in the lens.

Farooq M, Kaswala RH, Kleiman NJ, Kasinathan C, Frederikse PH.

Biochem Biophys Res Commun. 2012 Feb 10;418(2):273-7. doi: 10.1016/j.bbrc.2012.01.009. Epub 2012 Jan 10.

5.

Revisiting AMPA receptors as an antiepileptic drug target.

Rogawski MA.

Epilepsy Curr. 2011 Mar;11(2):56-63. doi: 10.5698/1535-7511-11.2.56.

6.

Isolated seizures in rats do not cause neuronal injury.

Acosta MT, Munashinge J, Zhang L, Guerron DA, Vortmeyer A, Theodore WH.

Acta Neurol Scand. 2012 Jan;125(1):30-7. doi: 10.1111/j.1600-0404.2011.01521.x. Epub 2011 May 26.

7.

Glutamate plasticity in the drunken amygdala: the making of an anxious synapse.

McCool BA, Christian DT, Diaz MR, L├Ąck AK.

Int Rev Neurobiol. 2010;91:205-33. doi: 10.1016/S0074-7742(10)91007-6. Review.

8.

Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Reddy DS, Gangisetty O, Briyal S.

Neuropharmacology. 2010 Dec;59(7-8):573-81. doi: 10.1016/j.neuropharm.2010.08.017. Epub 2010 Sep 8.

9.

Is epilepsy a preventable disorder? New evidence from animal models.

Giblin KA, Blumenfeld H.

Neuroscientist. 2010 Jun;16(3):253-75. doi: 10.1177/1073858409354385. Review.

10.

Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model.

Reddy DS, Rogawski MA.

Epilepsy Res. 2010 May;89(2-3):254-60. doi: 10.1016/j.eplepsyres.2010.01.009. Epub 2010 Feb 20.

11.

Arterial spin labeling demonstrates that focal amygdalar glutamatergic agonist infusion leads to rapid diffuse cerebral activation.

Munasinghe JP, Banerjee M, Acosta MT, Banks M, Heffer A, Silva AC, Koretsky A, Theodore WH.

Acta Neurol Scand. 2010 Mar;121(3):209-16. doi: 10.1111/j.1600-0404.2009.01188.x. Epub 2009 Nov 25.

12.

Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.

Fritsch B, Stott JJ, Joelle Donofrio J, Rogawski MA.

Epilepsia. 2010 Jan;51(1):108-17. doi: 10.1111/j.1528-1167.2009.02205.x. Epub 2009 Jul 20.

13.

Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesis.

Blumenfeld H, Lampert A, Klein JP, Mission J, Chen MC, Rivera M, Dib-Hajj S, Brennan AR, Hains BC, Waxman SG.

Epilepsia. 2009 Jan;50(1):44-55. doi: 10.1111/j.1528-1167.2008.01710.x. Epub 2008 Jul 14.

14.

Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy.

Aroniadou-Anderjaska V, Fritsch B, Qashu F, Braga MF.

Epilepsy Res. 2008 Feb;78(2-3):102-16. doi: 10.1016/j.eplepsyres.2007.11.011. Epub 2008 Jan 15. Review.

15.

Increased anxiety-like behavior and enhanced synaptic efficacy in the amygdala of GluR5 knockout mice.

Wu LJ, Ko SW, Toyoda H, Zhao MG, Xu H, Vadakkan KI, Ren M, Knifed E, Shum F, Quan J, Zhang XH, Zhuo M.

PLoS One. 2007 Jan 24;2(1):e167.

16.

Molecular targets for antiepileptic drug development.

Meldrum BS, Rogawski MA.

Neurotherapeutics. 2007 Jan;4(1):18-61. Review.

17.

Diverse mechanisms of antiepileptic drugs in the development pipeline.

Rogawski MA.

Epilepsy Res. 2006 Jun;69(3):273-94. Epub 2006 Apr 18. Review.

18.

The promise of new antiepileptic drugs.

Duncan JS.

Br J Clin Pharmacol. 2002 Feb;53(2):123-31. Review.

Supplemental Content

Support Center